Name : Mr.

Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

BIOCHEMISTRY

Fasting Glucose 92 mg/dL Normal Fasting Glucose: 70-99

F- fluoride plasma,GOD-POD Impaired Fasting Glucose: 100-
125
Diabetes : on more than one
occasion: > 126

Creatinine 0.7 mg/dL 0.66-1.25

Serum,Enzymatic

Uric Acid 5.4 mg/dL 3.5-8.5

Serum,Uricase

Page 1 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

LFT - LIVER FUNCTION TEST

Serum

Total Bilirubin 0.6 mg/dL Adult: 0.2-1.3

DSA Neonate: 1.0-10.5

Direct Bilirubin 0.3 mg/dL Neonate: 0.0-0.6

Calculated Adult: 0.0-0.3

Indirect Bilirubin 0.3 mg/dL Adult: 0.1-1.1

Dual wavelength Neonate: 0.6-10.5

Aspartate Transaminase(AST/ 27 U/L 17-49

SGOT)
MDH, UV Kinetic

Alanine Transaminase(ALT/ 22 U/L < 50

SGPT)
LDH, UV kinetic

Alkaline Phosphatase 79 U/L 38-126

PNPP, AMP Buffer

Gamma-Glutamyl Transferase 17 U/L 15-73

(GGT)
SZAZ Carboxylated Substrate

Total Protein 7.2 g/dL 6.0-8.3

Biuret

Albumin 4.2 g/dL 3.5-5.0

Bromo-Cresol Green

Globulin 3.0 g/dL 2.3-3.5

Calculated

A/G ratio 1.4 0.8-2.0

Calculated

Page 2 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

SGOT/SGPT- RATIO 1.2 0.7-1.4

Calculated

Total bilirubin is invariably increased in jaundice. Causes of jaundice are prehepatic, resulting from various hemolytic
diseases; hepatic, resulting from hepatocellular injury or obstruction; and posthepatic, resulting from obstruction of the
hepatic or common bile ducts.
Aspartate aminotransferase is present in high activity in heart, skeletal muscle, and liver. Increased serum AST activity
commonly follows myocardial infarction, pulmonary emboli, skeletal muscle trauma, alcoholic cirrhosis, viral hepatitis,
and drug-induced hepatitis.
Alanine aminotransferase is present in high activity in liver, skeletal muscle, heart, and kidney. Serum ALT increases
rapidly in liver cell necrosis, hepatitis, hepatic cirrhosis, liver tumours, obstructive jaundice, Reye’s syndrome,
extensive trauma to skeletal muscle, myositis, myocarditis, and myocardial infarction.
Alkaline phosphatase is elevated in fever and increased bone metabolism, for example, in adolescents and during the
healing of a fracture; primary and secondary hyperparathyroidism; Paget’s disease of bone; carcinoma metastatic to
bone; osteogenic sarcoma; and Hodgkin’s disease if bones are invaded. Hepatobiliary diseases involving cholestasis,
inflammation, or cirrhosis increased ALP activity; also increased in renal infarction and failure and in the complications
of pregnancy. Low ALP activity may occasionally be seen in hypothyroidism.
Serum GGT is a sensitive indicator of hepatobiliary disease and is useful in the diagnosis of obstructive jaundice and
chronic alcoholic liver disease, in the follow-up of chronic alcoholics undergoing treatment, and in the detection of
hepatotoxicity. GGT is more responsive to biliary obstruction than AST, ALT, or ALP.
Total serum protein levels can be used for evaluation of nutritional status. Causes of high total serum protein
concentration include dehydration, Waldenström’s macroglobulinemia, multiple myeloma, hyperglobulinemia,
granulomatous diseases, and some tropical diseases. Causes of low total serum protein concentration include
pregnancy, excessive intravenous fluid administration, cirrhosis or other liver diseases, chronic alcoholism, heart
failure, nephrotic syndrome, glomerulonephritis, neoplasia, protein-losing enteropathies, malabsorption, and severe
malnutrition.

Page 3 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Glycosylated Haemoglobin - (HbA1c)

Whole Blood

Glycosylated Haemoglobin 5.3 % Normal: < 5.7

(HbA1c) Pre-Diabetes: 5.7-6.4
HPLC Diabetes: >= 6.5

Mean Blood Glucose 105 mg/dL

Calculated

HbA1C is used to monitor fluctuations in blood glucose concentration in the past 8 to 12 week’s period.
The reference interval defined as per American Diabetes Association guidelines 2016:
a) Less than 5.7% : Non Diabetic
b) 5.7 to 6.4% : at increased risk of developing diabetes in the future
c) More than 6.5% : Diabetic
d) Therapeutic glycemic target:
i. Adults: less than 7%
ii. Children with Type 1 diabetes : less than 7 %
e) Pregnant diabetic patients : less than 6.5%

Note:
• Targets may be individualized based on: Age/life expectancy, Comorbid conditions, Diabetes duration , Hypoglycemia status,
Individual patient considerations
Reference: American Diabetes Association. Standards of medical care in diabetes—2021.
Mean Blood Glucose is average Blood glucose which directly correlates with A1C, reported in the same units as blood sugar levels
(mg/dl). Thus it reflects the average glucose concentration in the past 8 to 12 weeks period. This should not be compared with
Fasting or Post prandial or random blood sugar which measures glucose concentration at that point of time of testing.

Page 4 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Blood Urea Nitrogen (BUN)

Serum

Blood Urea Nitrogen (BUN) 10.3 mg/dL 6-20

Calculated

Urea 22 mg/dL 19-43

Urease Newborn: 6.5-25.5

Lipid Profile with calculated LDL

Serum

Total Cholesterol 172 mg/dl < 200

CHOD-POD

Triglycerides 173 mg/dL < 150

GPO-POD

HDL Cholesterol 23 mg/dL > 50

Direct

Non-HDL Cholesterol 149 mg/dL < 130

Calculated

LDL Cholesterol 114 mg/dL < 100

Calculated

VLDL Cholesterol 35 mg/dL < 30

Calculated

Cholesterol / HDL Ratio 7.5 3.30-4.40

Calculated

LDL:HDL RATIO 5 0.5-3.0

Calculated

HDL/LDL RATIO 0.2 Ratio > 0.4

Calculated

Page 5 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

REMARKS TOTAL CHOLESTEROL(mg/dL) TRIGLYCERIDE(mg/dL) LDL CHOLESTEROL(mg/dL)

Optimal <200 <150 <100
Above Optimal - - 100-129
Borderline 200-239 150-199 130-159
High >=240 200-499 160-189
Very High - >=500 >=190

Lipid profile is a group test consisting of various lipids. Lipid profiles are generally collected with overnight fasting. However, Recent guidelines have
recommended non fasting samples for lipid profile for assessment of cardiovascular risk. The details for the study can be checked at
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2733560

In certain instances measurements in the same patient can show physiological and analytical variations. In such cases three serial samples at an interval of 1
week each are recommended for Total cholesterol, TG, HDL and LDL.

Cholesterol levels are increased in primary hypercholesterolemia; secondary hyperlipoproteinemia, including nephrotic syndrome; primary biliary cirrhosis;
hypothyroidism; and in some cases, diabetes mellitus. Low cholesterol levels may be found in malnutrition, malabsorption, advanced malignancy, and
hyperthyroidism.

Triglyceride levels are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid
metabolism, or various endocrine disorders.

High Density Lipoprotein (HDL) cholesterol levels is used to evaluate the risk of developing coronary heart disease (CHD). The risk of CHD increases with
lower HDL cholesterol concentrations.

LDL (low-density lipoprotein) cholesterol level, sometimes called “bad” cholesterol, makes up most of our body’s cholesterol. High levels of LDL cholesterol
raise your risk for heart disease and stroke.

Very-low-density lipoprotein (VLDL) cholesterol is produced in the liver and released into the bloodstream to supply body tissues with triglycerides. High
levels of VLDL cholesterol have

been associated with the development of plaque deposits on artery walls, which narrow the passage and restrict blood flow.

Page 6 / 12

Dr. Sanchit Singhal Dr. Joan Maria Vynetta D ,

M.D
MD Pathologist
Pathologist
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

IMMUNOLOGY

Prostate Specific Antigen 0.961 ng/mL < 4.0

(PSA)
Serum,ECLIA

It is an aid in early detection of prostate cancer in males with PSA values between 4.0-10.0 and non
suspicious digital rectal examination.

Page 7 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Thyroid function test (TFT)

ECLIA

Total T3 1.03 ng/mL 0.97-1.69

Total T4 7.49 ug/dl 5.53-11.0

Thyroid Stimulating Hormone 2.214 µIU/mL 0.400-4.049

(TSH)

Page 8 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Thyroid Stimulating Hormone (TSH), also called Thyrotropin is a hormone secreted into the blood by the Pituitary gland (a gland present in the brain)). It
signals the thyroid gland to make and release the thyroid hormones (T3 & T4) into the blood.

High TSH level indicates that the thyroid gland is not making enough thyroid hormone (primary hypothyroidism).

Low TSH level usually indicates that the thyroid is producing too much thyroid hormone (hyperthyroidism).

Factors influencing TSH levels:

Fasting: TSH level shows a significant decline after meal intake in comparison to fasting values. This may have clinical implications in the diagnosis and
management of hypothyroidism, especially Subclinical hypothyroidism.1

Circadian Rhythm: TSH levels follow a circadian variation, reaching peak levels between Morning 2 – 4 am and at a minimum between Evening 6-10 pm.
The variation is of the order of 50%. hence time of sample collection during a day can significantly influence on the measured serum TSH concentrations.2

Other Factors: Genetics, Poisonous substances and radiation exposure, Inflammation of the thyroid gland, Deficiency or excess of iodine in the diet,
Pregnancy, Certain medications – antidepressants, cholesterol lowering drugs, chemotherapy drugs, steroids, Thyroid cancer.

References:

1. Indian Journal of Endocrinology and Metabolism 18(5):p 705-707, Sep–Oct 2014.)

2. efaidnbmnnnibpcajpcglclefindmkaj/http://www.pnei-it.com/1/upload/thyrotropin_secretion_patterns_i n_health_and_disease.pdf

In pregnant females the reference range of TSH differs. Please refer the table below for the same:-

PREGNANCY TSH REFERENCE RANGE (uIU/ml)

1st Trimester 0.100-2.500
2nd Trimester 0.200-3.00
3rd Trimester 0.300-3.00

Page 9 / 12

Dr. Sanchit Singhal

MD Pathologist
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

HEMATOLOGY

Complete Blood Count with ESR

Whole Blood

RBC count 4.18 mill/cu.mm 4.5-5.5

DC Impedance method

Haemoglobin (Hb) 14.3 gm/dL 13.0-17.0

Cyanide-free SLS method

Haematocrit(PCV) 41.6 % 40-50

Calculated

Mean Corpuscular Volume 99.6 fL 83-101

(MCV)
Calculated

Mean Corpuscular 34.2 pg 27-32

Haemoglobin(MCH)
Calculated

Mean Corpuscular 34.4 g/dL 31.5-34.5

Haemoglobin Concentration
(MCHC)
Calculated

Red cell distribution width 13.7 % 11.6-14.0

(RDW)
Calculated

Mentzer Index 23.8 Index Beta Thalassemia trait: < 14

Calculated Iron deficiency anaemia: >= 14

Sehgal index 2373.2 Index Beta Thalassemia trait: < 972

Calculated Iron deficiency anaemia: >= 972

Page 10 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Total WBC count- TC 6270 cells/cu.mm 4000-10000

Differential Leucocyte Count - DC

Flow Cytometry

Neutrophils 51.4 % 40-80

Lymphocytes 41.8 % 20-40

Monocytes 4.5 % 2-10

Eosinophils 1.8 % 1-6

Basophils 0.5 % 0-2

Absolute Neutrophil Count 3223 / cu.mm 2000-7000

Calculated

Absolute Lymphocyte Count 2621 / cu.mm 1000-3000

Calculated

Absolute Monocyte Count 282 / cu.mm 200-1000

Calculated

Absolute Eosinophil Count 113 / cu.mm 20-500

Calculated

Absolute Basophil Count 31 / cu.mm 0-100

Calculated

Neutrophil Lymphocyte Ratio 1.2 Ratio 1.0-3.0

(NLR)
Calculated

Page 11 / 12
Name : Mr. Guruprasad Sadashiv Age / Sex : 41 Year(s) / Male Collected On : 26/12/2023 08:36 AM

Patient ID : OHPEAI6L611332 Ref. Doctor : Received On : 26/12/2023 10:26 AM

Visit No. : BL68200201 Client : Ekin care (HYD) Reported On : 26/12/2023 12:35 PM

Test Results Units Biological Reference Interval

Platelet count 207 10^3/ul 150-450

DC Impedance method

Platelet hematocrit 0.219 % 0.20-0.50

Calculated

Mean Platelet Volume (MPV) 10.6 fL 7-13

Calculated

Erythrocyte Sedimentation 3 mm/hr 0-10

Rate
Quantitative Capillary Photometry

1. Reference Ranges are in accordance with Dacie & Lewis Practical Hematology International Edition (12th).
2. As per International Council for Standardization in Hematology's recommendations Differential Leucocyte counts are additionally reported in
Absolute numbers in each cell per unit volume of blood.

-- End of Report --

Page 12 / 12

Dr. Sanchit Singhal Dr. Joan Maria Vynetta D ,

M.D
MD Pathologist
Pathologist